Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05146362 · ClinicalTrials.gov registry record · NA
Vermont RETAIN Impact Evaluation
A NA study, sponsored by Mathematica Policy Research.
- Completed
- Registry status
- NA
- Development phase
- 798
- Enrollment target
NCT05146362 is a NA study that has completed, run by Mathematica Policy Research. The registered enrollment target is 798 participants.
The verdict
NCT05146362, a NA study, has completed, sponsored by Mathematica Policy Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 798 participants
- Enrollment target
Study Summary
The Retaining Employment and Talent after Injury/Illness Network (RETAIN) demonstration is a collaborative effort between the U.S. Department of Labor (DOL) and the Social Security Administration (SSA) to improve employment outcomes for individuals who experience injuries or illnesses that put them at risk of exiting the labor force and relying on disability programs and other public supports in the long term. RETAIN projects include a combination of medical provider services, stay-at-work/return-to-work (SAW/RTW) coordination services, and other SAW/RTW services. This evaluation will focus on the Vermont Department of Labor's implementation of "Vermont RETAIN" statewide. The evaluation will document how the project is implemented, describe enrollees, estimate the project's impacts on enrollees' outcomes, and assess whether the benefits outweigh the costs.
Interventions
- OTHER Vermont RETAIN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 798 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05146362
The ClinicalTrials.gov registry entry for NCT05146362 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 798 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mathematica Policy Research, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vermont RETAIN is the first listed.
NCT05146362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05146362 about?
NCT05146362 is a clinical study titled "Vermont RETAIN Impact Evaluation". The Retaining Employment and Talent after Injury/Illness Network (RETAIN) demonstration is a collaborative effort between the U.S. Department of Labor (DOL) and the Social Security Administration (SSA) to improve employment outcomes for individuals who experience injuries or illnesses that put them ...
What is the current status of trial NCT05146362?
This trial is currently completed. It is a NA study. The enrollment target is 798 participants. The study started on 2022-02-01. Estimated completion is 2026-02-28.
What interventions are being tested in trial NCT05146362?
The interventions under investigation include: Vermont RETAIN (OTHER).
Who is sponsoring clinical trial NCT05146362?
This trial is sponsored by Mathematica Policy Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.